Medx Health (TSXV:MDX) ROCE % : 0.00% (As of Sep. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Medx Health ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Medx Health's annualized ROCE % for the quarter that ended in Sep. 2024 was 0.00%.

Medx Health ROCE % Historical Data

The historical data trend for Medx Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medx Health ROCE % Chart

Medx Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

Medx Health Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															-	-	-	-	-

Medx Health ROCE % Calculation

Medx Health's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-2.431	/	( ( (0.718 - 6.922)	+	(0.69 - 6.949) )	/ 2 )
	=	-2.431	/	( (-6.204	+	-6.259)	/ 2 )
	=	-2.431	/	-6.2315
	=	39.01 %

Medx Health's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-1.948	/	( ( (0.854 - 8.268)	+	(0.876 - 8.852) )	/ 2 )
	=	-1.948	/	( ( -7.414	+	-7.976 )	/ 2 )
	=	-1.948	/	-7.695
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Medx Health (TSXV:MDX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Medx Health ROCE % Related Terms

Thank you for viewing the detailed overview of Medx Health's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medx Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medx Health Corp (TSXV:MDX) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1495 Bonhill Road, Unit 1, Mississauga, ON, CAN, L5T 1M2

Website

https://www.medxhealth.com

Medx Health Corp is engaged in the development, manufacturing, and marketing of skin-related screening tools and phototherapy devices for pain relief and tissue repair. Its two main product lines are; SIAscopy, a medical device technology that is used to scan skin for suspicious moles and lesions; and Phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide effective treatment of pain and tissue damage in the rehabilitation market. It derives key revenue from the sale of Phototherapeutic lasers. The company sells its products internationally, of which prime revenue is generated in Canada and the United States.

Executives

Edmund Ho	Director
Stephen Owen Lockyer	Director
David John Hennigar	Director
Luigi Canitano	Senior Officer
Gary Norman Van Nest	Director

Medx Health Headlines

No Headlines